ViroStatics, srl is an Italian/USA biopharmaceutical company with a focus on research and development for the treatment of infectious diseases such as HIV (AIDS) and hepatitis C and cancer. The company is developing first-in-class AV-HALT antiretroviral drugs for the treatment of AIDS and other chronic diseases.